Rongyan Peng
Overview
Explore the profile of Rongyan Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun L, Xu Y, Chen N, Zhang C, Wu A, Wang H, et al.
Eur J Cancer
. 2024 Nov;
213:115109.
PMID: 39509846
Purpose: Many cancer patients express interest in using herbal medicine during chemotherapy, but little is known about its benefits and risks. This study aimed to evaluate the effects of the...
2.
Qian M, Peng R, Yue C, Yang Z, Zhu H, Liu B, et al.
Evid Based Complement Alternat Med
. 2024 Sep;
2020:6426383.
PMID: 39295891
Chaihu Shugan San (CHSGS) is a traditional Chinese herbal formula that is often used in clinical practice to treat live Qi stagnation syndrome and depression. Fluoxetine is one of the...
3.
Yan Y, Liu J, Pang Y, Wang Z, Peng R, Jiang D, et al.
BMC Complement Med Ther
. 2024 Jul;
24(1):290.
PMID: 39080684
Background: More than 50% of colorectal cancer(CRC) patients experience cancer-related psychological burden after radical surgery, which can seriously affect their physical wellness, quality of life and even survival outcomes. Our...
4.
Sun L, Pang Y, Wang Z, Liu J, Peng R, Yan Y, et al.
Support Care Cancer
. 2023 Nov;
31(12):698.
PMID: 37964024
Objective: To evaluate the efficacy and feasibility of utilizing Traditional Chinese Medicine (TCM) combined group psychotherapy intervention on psychological distress management and gut micro-biome regulation for colorectal (CRC) survivors. Methods:...
5.
Wang R, Cheng N, Peng R, Yu Z, Nan M, Cao H
BMC Complement Med Ther
. 2020 Oct;
20(1):303.
PMID: 33028282
Background: Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy complication whose range has been calculated to be between 0.01 and 15.6% all around the world. We wanted to systematically evaluate...